TipRanks
Go Ultimate55% OFF

CNS Pharmaceuticals (CNSP) Balance Sheet

CNS Pharmaceuticals Balance Sheet

CNS Pharmaceuticals's total assets for Q2 2026 were $21.94M, an increase of 371.46% from the previous quarter. CNSP total liabilities were $3.74M for the fiscal quarter, a 18.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Mar 25Mar 24Dec 22Dec 21
$ 8.62M$ 8.70M$ 1.70M$ 13.05M$ 8.76M
$ 4.10M$ 2.52M$ 6.13M$ 4.92M$ 2.14M
$ 4.52M$ 6.18M$ -4.43M$ 8.13M$ 6.62M

Currency in USD

CNS Pharmaceuticals Debt to Assets

06M12M18M0 %150 %300 %450 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets